Of 68 patients, 45 (66%) had exercise intolerance 6 months after pulmonary endarterectomy, with exercise intolerance primarily caused by a cardiovascular limitation in 20 of these patients.

William R. Auger, Kim M. Kerr, Nick H. Kim, Peter F. Fedullo, Evaluation of patients with chronic thromboembolic pulmonary hypertension for pulmonary endarterectomy ...

Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, found that patients treated surgically for segmental Chronic Thromboembolic Pulmonary Hypertension ...

Management of chronic thromboembolic pulmonary hypertension (CTEPH) includes multimodal therapy that depends on expert centres' experience.1,2 Guidelines advocate for pulmonary endarterectomy (PEA) to ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Pulmonary-artery catheterization aids the diagnosis and management of numerous cardiovascular illnesses, including pulmonary hypertension, cardiogenic shock, mixed shock states, cardiac tamponade ...

Inclusion criteria included a 6-min walk distance of 150–450 m, mean pulmonary artery pressure of ≥25 mmHg, and pulmonary vascular resistance >300 dyn·sec/cm 5.

A working group was formed to address key questions related to the utility of imaging for the recognition, work-up, treatment, and follow-up of patients with pulmonary hypertension.

A ratio of pulmonary artery to aorta diameter that is greater than 1 is significantly and independently associated with risk for a severe exacerbation in patients with COPD.

The pulmonary artery occlusion pressure did not change significantly (19 mm Hg at baseline vs. 15 mm Hg at 3 months P =.281). There was also a drop in N-terminal B-type natriuretic peptide (NP-BNP) in ...

A new drug appears to have promising-- but not game-changing-- effects in people with two forms of pulmonary hypertension. Riociguat, a soluble guanylate cyclase stimulator under development by ...